Salarius Pharmaceuticals Inc. (SLRX) Live Share Price, Invest From India

Salarius Pharmaceuticals Inc. Stock Performance

as on December 5, 2025 at 8:36 pm IST

Day's Low
Day's High
$0.88
Day's Price Range
$0.91
$0.9
2.22%
Downside
1.11%
Upside
52 Week's Low
52 Week's High
$0.71
52-Week Price Range
$108
$0.9
21.04%
Downside
11900.00%
Upside

Salarius Pharmaceuticals Inc. share price movements today

Previous Close: $0.87
Open: $0.91
Volume: 71.6K
Day's Low - High: $0.88 - $0.91
52 Week Low - High: $0.71 - $108

Salarius Pharmaceuticals Inc. Historical Returns

1 Month Return: -70.26 %
3 Month Return: -81 %
1 Year Return: -95.86 %
3 Year Return: -99.55 %
5 Year Return: -99.97 %

Salarius Pharmaceuticals Inc. Stock Fundamentals & Key Indicators

Check Salarius Pharmaceuticals Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$5.0M

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-5.6M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-139.55%

Salarius Pharmaceuticals Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Salarius Pharmaceuticals Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Salarius Pharmaceuticals Inc.	SELL	$5.0M	-99.97%	NA	0.00%
Insmed Incorporated	BUY	$43.7B	410.81%	-16.34	-264.83%
Alnylam Pharmaceuticals, Inc.	BUY	$62.5B	258.57%	1690.32	1.36%
Vertex Pharmaceuticals Incorporated	BUY	$118.7B	100.27%	30.49	31.35%
Regeneron Pharmaceuticals, Inc.	BUY	$76.7B	46.78%	17.33	32.13%

Stock Returns calculator for Salarius Pharmaceuticals Inc. Stock including INR - Dollar returns

The Salarius Pharmaceuticals Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Salarius Pharmaceuticals Inc. investment value today

Current value as on today

₹10,312

Returns

₹89,688

(-89.69%)

Returns from Salarius Pharmaceuticals Inc. Stock

₹95,833 (-95.83%)

Dollar Returns*

₹6,146 (+6.15%)

Analyst Recommendation on Salarius Pharmaceuticals Inc. Stock

Based on 6 analysts

SELL

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for Salarius Pharmaceuticals Inc.. Average target price of $26

Salarius Pharmaceuticals Inc. Share Price Target

Get share price movements and forecasts by analysts on Salarius Pharmaceuticals Inc..

What analysts predicted

96.54%UPSIDE

Target Price

$26

Current Price

$0.9

Analyzed by

6 Analysts

Target

$26.00

Salarius Pharmaceuticals Inc. target price $26, a slight upside of 96.54% compared to current price of $0.9. According to 6 analysts rating.

Salarius Pharmaceuticals Inc. Stock’s Investor Sentiment and Interest

Investment in Salarius Pharmaceuticals Inc. Shares on INDmoney has grown by 1150.00% over the past 30 days, indicating increased transactional activity.

Time period: November 5, 2025 to December 5, 2025

Change:1150.00% versus previous 30 day period

Search interest for Salarius Pharmaceuticals Inc. Stock has increased by 1522% in the last 30 days, reflecting an upward trend in search activity.

Time period: November 5, 2025 to December 5, 2025

Change:1522% versus previous 30 day period

Salarius Pharmaceuticals Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	-	-	0	-	-	-	0	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-3	-2	0	-1	-1	-1	-1	-1	0	0
EBITDA	-3	-2	0	-1	-1	-1	-1	-1	0	0
Interest Expense	-	-	0	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-3	-2	0	-1	-1	0	-1	-1	0	0
Income Tax Expense	0	0	0	0	0	-	-	-	-	-
Net Income	-3	-2	0	-1	-1	0	-1	-1	0	0
Net Profit Margin	0.00%	0.00%	-4928.44%	0.00%	0.00%	0.00%	-33075.76%	0.00%	0.00%	0.00%

Salarius Pharmaceuticals Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	1	1	0	3	5	1	-	-	-
Gross Profit	0	0	0	3	5	1	0	0	0
Operating Income	-39	-34	-22	-8	-7	-12	-31	-12	-5
EBITDA	-39	-34	-21	-8	-7	-12	-22	-12	-5
Interest Expense	-	-	-	-	0	0	0	-	-
Depreciation	-	0	0	0	0	0	0	0	0
Income Before Tax	-39	-34	-21	-6	-7	-12	-31	-12	-5
Income Tax Expense	0	0	0	-1	0	0	0	-12	-5
Net Income	-39	-34	-21	-6	-7	-12	-31	-12	-5
Net Profit Margin	-3906.33%	-2700.71%	-2615.99%	-200.18%	-140.49%	-693.84%	0.00%	0.00%	0.00%

Salarius Pharmaceuticals Inc. Quarterly Cash Flow

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Net Income	-2	0	-1	-1	0	-1	-1	0	0
Operating Cash Flow	-3	-1	-1	-1	-1	0	-1	0	-1
Investing Cash Flow	-	-	-	-	-	-	-	-	0
Financing Cash Flow	0	0	0	0	1	0	0	0	5
Change in Cash	-3	-1	-1	-1	0	0	0	-1	4

Salarius Pharmaceuticals Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-39	-34	-21	-6	-7	-12	-31	-12	-5
Operating Cash Flow	-32	-27	-23	-11	-10	-10	-17	-12	-4
Investing Cash Flow	-12	24	14	5	0	-1	-1	-	-
Financing Cash Flow	0	0	0	3	17	28	1	6	1
Change in Cash	-44	-3	-9	-2	7	18	-17	-6	-3

Global Institutional Holdings in Salarius Pharmaceuticals Inc.

Funds	Holdings
HRT FINANCIAL LLC	0.41%
UBS Group AG	0.24%
Cubist Systematic Strategies, LLC	0.22%
Goldman Sachs Group Inc	0.22%
Geode Capital Management, LLC	0.2%

See all

Insights on Salarius Pharmaceuticals Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Insmed Incorporated has given 930.9% return, outperforming this stock by 1030.4%
NO EFFECT
Against Peers
In the last 1 year, Insmed Incorporated has given 172.2% return, outperforming this stock by 268.1%
NEGATIVE IMPACT
Price Dip
In the last 1 month, SLRX stock has moved down by -70.3%

About Salarius Pharmaceuticals Inc.

salarius is an oncology based biotechnology company developing targeted treatments for patients who need them the most.

Organisation	Salarius Pharmaceuticals Inc.
Headquarters	2450 Holcombe Blvd., Houston, TX, United States, 77021
Industry	Health Technology
CEO	Mr. Frederick E. Pierce II
E-voting on shares	Click here to vote

Key Management of Salarius Pharmaceuticals Inc.

Name	Title
Dr. Shahin Gharakhanian DPH, M.D.	Chairman of the Scientific Advisory Board & Acting Chief Medical Officer
Mr. Peter K. Marschel M.B.A., M.S.	Chief Business Officer
Mr. Frederick E. Pierce II	Chief Executive Officer
Ms. Jodi Cooper M.S.	Director of Operations
Dr. Michael M. Lipp Ph.D.	Chief Technology Officer
Ms. Barb Hibner Ph.D.	Chief Scientific Officer

FAQs

What is Salarius Pharmaceuticals Inc. share price today?

Salarius Pharmaceuticals Inc. share price today is $0.9 as on December 5, 2025 at 8:36 pm IST. Salarius Pharmaceuticals Inc. share today touched a day high of $0.91 and a low of $0.88.

What is the 52 week high and 52 week low for Salarius Pharmaceuticals Inc. share?

Salarius Pharmaceuticals Inc. share touched a 52 week high of $108 on January 13, 2025 and a 52 week low of $0.71 on November 19, 2025. Salarius Pharmaceuticals Inc. stock price today i.e. December 5, 2025 at 8:36 pm IST is trending at $0.9,which is 99.17% down from its 52 week high and 26.65% up from its 52 week low.

What is Salarius Pharmaceuticals Inc.'s market capitalisation today?

Salarius Pharmaceuticals Inc. market capitalisation is $0.00T as on December 5, 2025 at 8:36 pm IST.

How to invest in Salarius Pharmaceuticals Inc. Stock (SLRX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Salarius Pharmaceuticals Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Salarius Pharmaceuticals Inc. Shares that will get you 1.6667 shares as per Salarius Pharmaceuticals Inc. share price of $0.9 per share as on December 5, 2025 at 8:36 pm IST.

What is the minimum amount required to buy Salarius Pharmaceuticals Inc. Stock (SLRX) from India?

Indian investors can start investing in Salarius Pharmaceuticals Inc. (SLRX) shares with as little as ₹89.927 or $1 (as of December 5, 2025 at 8:39 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹899.27 in Salarius Pharmaceuticals Inc. stock (as per the Rupee-Dollar exchange rate as on December 5, 2025 at 8:39 pm IST). Based on Salarius Pharmaceuticals Inc. share’s latest price of $0.9 as on December 5, 2025 at 8:36 pm IST, you will get 11.1111 shares of Salarius Pharmaceuticals Inc.. Learn more about fractional shares .

What are the returns that Salarius Pharmaceuticals Inc. has given to Indian investors in the last 5 years?

Salarius Pharmaceuticals Inc. stock has given -99.97% share price returns and 21.47% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?